Article

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152

2021-08-01

Abstract excerpt

The recent emergence of the SARS-CoV-2 Variant of Concern, B.1.617.2 (Delta) variant and its high transmissibility has led to the second wave in India. BBV152, a whole-virion inactivated SARS-CoV-2 vaccine used for mass immunization in India, showed a 65.2% protection against the Delta variant in a double-blind, randomized, multicentre, phase 3 clinical trial. Subsequently, Delta has been further mutated to Delta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 12cf4573-4690-5182-9fa7-d412ea871847
DOI: 10.1101/2021.07.30.454511

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152DOI 10.1101/2021.07.30.454511Read

SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthroughSemantic proximity Read

Neutralization of SARS-CoV-2 variants B.1.617.1 and B.1.525 by BNT162b2-elicited seraSemantic proximity Read

SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient seraSemantic proximity Read

Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individualsSemantic proximity Read

Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine-induced antibodies.Semantic proximity Read

Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 VaccineesSemantic proximity Read

SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodiesSemantic proximity Read

Effectiveness of BBV152 vaccine against SARS-CoV-2 infections, hospitalizations and deaths among healthcare workers in the setting of high delta variant transmission in New Delhi, IndiaSemantic proximity Read

Effectiveness of BBV152/Covaxin and AZD1222/Covishield Vaccines Against Severe COVID-19 and B.1.617.2/Delta Variant in India, 2021: A Multi-Centric Hospital-Based Case-Control StudySemantic proximity Read

Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individualsSemantic proximity Read

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape.Semantic proximity Read

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein VaccineSemantic proximity Read